Skip to main content
. 2021 Oct 1;41(12):2091–2103. doi: 10.1007/s00296-021-04987-0

Fig. 4.

Fig. 4

a Structure of publications by their type. b The 5 most represented rheumatologic disorders considering COVID-19 topic. c The most frequently mentioned rheumatologic drugs in COVID-19 related articles. d The authors with the most significant contribution to the field